BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10936806)

  • 1. Clinical relevance of cytokine production in hemodialysis.
    Pertosa G; Grandaliano G; Gesualdo L; Schena FP
    Kidney Int Suppl; 2000 Aug; 76():S104-11. PubMed ID: 10936806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The link of biocompatibility to cytokine production.
    Panichi V; Migliori M; De Pietro S; Taccola D; Andreini B; Metelli MR; Giovannini L; Palla R
    Kidney Int Suppl; 2000 Aug; 76():S96-103. PubMed ID: 10936805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
    Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
    Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis-associated induction of cytokines.
    Lonnemann G; Haubitz M; Schindler R
    Blood Purif; 1990; 8(4):214-22. PubMed ID: 2085429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.
    Girndt M; Lengler S; Kaul H; Sester U; Sester M; Köhler H
    Am J Kidney Dis; 2000 Jan; 35(1):95-104. PubMed ID: 10620550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatible characteristics of high-performance membranes.
    Uda S; Mizobuchi M; Akizawa T
    Contrib Nephrol; 2011; 173():23-29. PubMed ID: 21865772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes.
    Pertosa G; Grandaliano G; Gesualdo L; Ranieri E; Monno R; Schena FP
    Kidney Int; 1998 Aug; 54(2):570-9. PubMed ID: 9690225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
    Balakrishnan VS; Guo D; Rao M; Jaber BL; Tighiouart H; Freeman RL; Huang C; King AJ; Pereira BJ;
    Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
    Lin YF; Chang DM; Shaio MF; Lu KC; Chyr SH; Li BL; Sheih SD
    Am J Nephrol; 1996; 16(4):293-9. PubMed ID: 8739281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine production in haemodialysis.
    Memoli B
    Blood Purif; 1999; 17(2-3):149-58. PubMed ID: 10449873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The study of IL-1 beta, TNF-alpha, IL-6 gene expression and plasma levels on hemodialysis before and after dialyzer reuse.
    Qian J; Yu Z; Dai H; Huang P; Zhang Q; Cheng F; Chen S
    Chin Med J (Engl); 1997 Jul; 110(7):508-11. PubMed ID: 9594206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bioincompatibility in dialysis morbidity and mortality.
    Lazarus JM; Owen WF
    Am J Kidney Dis; 1994 Dec; 24(6):1019-32. PubMed ID: 7985663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biocompatibility study--inflammable cytokine production by the extract from fiber membrane in human peripheral blood].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):496-503. PubMed ID: 7969016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of cytokine production capacity during dialysis--a new dynamic method for the evaluation of biocompatibility?
    Guth HJ; Gruska S; Kraatz G
    Int J Artif Organs; 2000 Oct; 23(10):675-9. PubMed ID: 11075897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.
    Rostaing L; Peres C; Tkaczuk J; Charlet JP; Bories P; Durand D; Ohayon E; de Préval C; Abbal M
    Am J Nephrol; 2000; 20(1):18-26. PubMed ID: 10644863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and carnitine in hemodialysis patients.
    Pertosa G; Grandaliano G; Simone S; Soccio M; Schena FP
    J Ren Nutr; 2005 Jan; 15(1):8-12. PubMed ID: 15647999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness.
    Yuen D; Richardson RM; Fenton SS; McGrath-Chong ME; Chan CT
    ASAIO J; 2005; 51(3):236-41. PubMed ID: 15968953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytokines in the response to erythropoietin in hemodialysis patients.
    Goicoechea M; Martin J; de Sequera P; Quiroga JA; Ortiz A; Carreño V; Caramelo C
    Kidney Int; 1998 Oct; 54(4):1337-43. PubMed ID: 9767553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis.
    Rysz J; Banach M; Cialkowska-Rysz A; Stolarek R; Barylski M; Drozdz J; Okonski P
    Cell Mol Immunol; 2006 Apr; 3(2):151-4. PubMed ID: 16696903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.